文献速递白血病

生理药代动力学建模在儿童急性淋巴细胞白血病中的概念验证

Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2024-03-17

本研究基于两项随机双盲II/III期临床试验数据,构建并验证了儿童急性淋巴细胞白血病患者中重组L-天冬酰胺酶的全身生理药代动力学模型,其药代动力学参数预测与群体药代动力学模型偏差为13%。

要点

  • 构建了首个非抗体治疗性蛋白的全身生理药代动力学模型
  • 模型预测的L-天冬酰胺酶谷浓度中位数与群体药代动力学模型偏差13%
  • 最终模型参数:清除率0.0569 L/h/19.5 kg,分布容积1.251 L,半衰期18.5 h,谷浓度140.9 IU/L

核心结论

  • 生理药代动力学模型可准确描述儿童急性淋巴细胞白血病患者中重组L-天冬酰胺的药代动力学,预测性能与群体药代动力学模型相当。

研究设计与样本

  • 基于两项随机双盲II/III期临床试验(MC-ASP.4/ALL和MC-ASP.5/ALL)的数据,分别用于建立和评估最终模型。

主要发现

  • 最终群体药代动力学参数:清除率0.0569 L/h/19.5 kg,分布容积1.251 L,半衰期18.5 h,谷浓度140.9 IU/L。
  • 模型预测的L-天冬酰胺酶谷浓度中位数与独立开发的群体药代动力学模型偏差为13%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Physiologically based pharmacokinetic (PBPK) modelling is an alternative modelling technique that is increasingly used in pharmacokinetics. Due to its nature, it can be complementarily employed to population pharmacokinetics, especially when it comes to small population size. Here, we report the proof of concept of its application to accurately describe the pharmacokinetics of a recombinant L-asparaginase in paediatric patients with acute lymphoblastic leukaemia. Data from two randomized, double-blind, phase II/III clinical studies (MC-ASP.4/ALL; MC-ASP.5/ALL) were included to setup and evaluate the final model, respectively. Final population values for basic pharmacokinetic parameters were calculated (clearance: 0.0569 L/h/19.5 kg, volume of distribution: 1.251 L, half-life: 18.5 h, trough concentration: 140.9 IU/L). Pharmacokinetic parameter prediction as well as predictive performance of the model proofed to be comparable to a separately developed population pharmacokinetic model with 13% deviation in predicted median L-asparaginase trough levels. To the best of our knowledge, this is the first whole-body PBPK model of a non-antibody therapeutic protein.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Bauch T, Hempel G. Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia. Br J Haematol. 2024. PMID: 38494194. doi:10.1111/bjh.19410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。